Table 1.
Demographic and clinical characteristics of the quantitative and qualitative analysis participants
| Characteristic | Quantitative analysis | Qualitative analysis | ||
|---|---|---|---|---|
|
|
|
|||
| Community-based club arm (n = 277) | Clinic-based club arm (n = 291) | Community-based club arm (n = 19) | Clinic-based club arm (n = 17) | |
|
| ||||
| Female sex, n (%) | 179 (67) | 186 (65) | 15 (79) | 10 (59) |
| Age, median (IQR) | 38 (32–44) | 38 (33–43) | 36 (24–41) | 41 (33–47) |
| Age category | ||||
| 18–29 years, n (%) | 32 (12) | 27 (13) | 2 (11) | 2 (13) |
| 30–44 years, n (%) | 169 (64) | 189 (66) | 14 (74) | 7 (44) |
| 45+ years, n (%) | 65 (24) | 60 (21) | 3 (16) | 7 (44) |
| Unemployed, n (%) | 58 (22) | 42 (15) | 2 (11) | 3 (19) |
| On FDC, n (%) | 238 (89) | 253 (88) | 16 (84) | 14 (88) |
| Hypertensive, n (%) | 18 (7) | 19 (7) | 0 (0) | 2 (13) |
| Baseline CD4 (IQR) | 467 (335–654) | 537 (398–705) | 516 (318–784) | 428 (274–656) |
| CD4 category | ||||
| < 350, n (%) | 75 (28) | 55 (19) | 6 (32) | 7 (44) |
| 350–499, n (%) | 67 (25) | 69 (24) | 3 (16) | 3 (19) |
| ≥ 500, n (%) | 123 (47) | 162 (57) | 10 (53) | 6 (38) |
ART antiretroviral treatment, FDC fixed dose combination antiretroviral treatment, IQR interquartile range